Akinci DAntonoli T, Cavallo A, Kocak B, Borgheresi A, Ponsiglione A, Stanzione A
Eur Radiol. 2025; .
PMID: 39969552
DOI: 10.1007/s00330-025-11443-1.
Zhao B, Dercle L, Yang H, Riely G, Kris M, Schwartz L
Sci Data. 2024; 11(1):1259.
PMID: 39567508
PMC: 11579286.
DOI: 10.1038/s41597-024-04085-3.
Luo T, Yan M, Zhou M, Dekker A, Appelt A, Ji Y
Radiol Med. 2024; 130(1):96-109.
PMID: 39542968
DOI: 10.1007/s11547-024-01919-3.
Alhashim M, Anan N, Tamal M, Altarrah H, Alshaibani S, Hill R
BJR Open. 2024; 6(1):tzae034.
PMID: 39483333
PMC: 11525052.
DOI: 10.1093/bjro/tzae034.
Deasy J
Semin Radiat Oncol. 2024; 34(4):379-394.
PMID: 39271273
PMC: 11698470.
DOI: 10.1016/j.semradonc.2024.07.012.
Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas.
Zhou Q, Zhang B, Xue C, Ren J, Zhang P, Ke X
Strahlenther Onkol. 2024; .
PMID: 39269469
DOI: 10.1007/s00066-024-02289-5.
CT-based radiomics for predicting breast cancer radiotherapy side effects.
Llorian-Salvador O, Windeler N, Martin N, Etzel L, Andrade-Navarro M, Bernhardt D
Sci Rep. 2024; 14(1):20051.
PMID: 39209947
PMC: 11362146.
DOI: 10.1038/s41598-024-70723-w.
A comparative analysis of preclinical computed tomography radiomics using cone-beam and micro-computed tomography scanners.
Brown K, Kerr B, Pettigrew M, Connor K, Miller I, Shiels L
Phys Imaging Radiat Oncol. 2024; 31:100615.
PMID: 39157293
PMC: 11328005.
DOI: 10.1016/j.phro.2024.100615.
Comprehensive multimodal deep learning survival prediction enabled by a transformer architecture: A multicenter study in glioblastoma.
Gomaa A, Huang Y, Hagag A, Schmitter C, Hofler D, Weissmann T
Neurooncol Adv. 2024; 6(1):vdae122.
PMID: 39156618
PMC: 11327617.
DOI: 10.1093/noajnl/vdae122.
A F-FDG PET/CT based radiomics nomogram for predicting disease-free survival in stage II/III colorectal adenocarcinoma.
Wang B, Hu T, Shen R, Liu L, Qiao J, Zhang R
Abdom Radiol (NY). 2024; 50(1):64-77.
PMID: 39096393
DOI: 10.1007/s00261-024-04515-1.
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights.
Sujit S, Aminu M, Karpinets T, Chen P, Saad M, Salehjahromi M
Nat Commun. 2024; 15(1):3152.
PMID: 38605064
PMC: 11009351.
DOI: 10.1038/s41467-024-47512-0.
A distributed feature selection pipeline for survival analysis using radiomics in non-small cell lung cancer patients.
Gottardelli B, Gouthamchand V, Masciocchi C, Boldrini L, Martino A, Mazzarella C
Sci Rep. 2024; 14(1):7814.
PMID: 38570606
PMC: 10991291.
DOI: 10.1038/s41598-024-58241-1.
A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
Yu L, Zhang Z, Yi H, Wang J, Li J, Wang X
Radiat Oncol. 2024; 19(1):10.
PMID: 38254106
PMC: 10802016.
DOI: 10.1186/s13014-024-02402-z.
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII.
Kocak B, Akinci DAntonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I
Insights Imaging. 2024; 15(1):8.
PMID: 38228979
PMC: 10792137.
DOI: 10.1186/s13244-023-01572-w.
Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma.
Frood R, Mercer J, Brown P, Appelt A, Mistry H, Kochhar R
Eur Radiol. 2023; 34(5):3194-3204.
PMID: 37924344
PMC: 11126458.
DOI: 10.1007/s00330-023-10340-9.
Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics.
Kazmierski M, Welch M, Kim S, McIntosh C, Rey-McIntyre K, Huang S
Cancer Res Commun. 2023; 3(6):1140-1151.
PMID: 37397861
PMC: 10309070.
DOI: 10.1158/2767-9764.CRC-22-0152.
Explainable machine learning via intra-tumoral radiomics feature mapping for patient stratification in adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Teng X, Zhang J, Han X, Sun J, Lam S, Ai Q
Radiol Med. 2023; 128(7):828-838.
PMID: 37300736
DOI: 10.1007/s11547-023-01650-5.
Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I).
Bernatz S, Both I, Ackermann J, Burck I, Mahmoudi S, Lenga L
BMC Med Imaging. 2023; 23(1):71.
PMID: 37268876
PMC: 10236822.
DOI: 10.1186/s12880-023-01034-1.
Development and optimisation of a preclinical cone beam computed tomography-based radiomics workflow for radiation oncology research.
Brown K, Payan N, Osman S, Ghita M, Walls G, Patallo I
Phys Imaging Radiat Oncol. 2023; 26:100446.
PMID: 37252250
PMC: 10213103.
DOI: 10.1016/j.phro.2023.100446.
Textural Features of Mouse Glioma Models Measured by Dynamic Contrast-Enhanced MR Images with 3D Isotropic Resolution.
Kiser K, Zhang J, Kim S
Tomography. 2023; 9(2):721-735.
PMID: 37104129
PMC: 10141208.
DOI: 10.3390/tomography9020058.